Education
About Us
Working with TipRanks
Follow Us
Organogenesis Holdings (ORGO)
:ORGO
Earnings Data
Report Date
Feb 26, 2026After Close (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
0.22Last Year’s EPS
0.04Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
Earnings Call Summary
Q3 2025
Earnings Call Date:Nov 06, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
The earnings call presented a strong performance in terms of revenue growth, exceeding guidance, and positive developments with CMS policy changes. However, there were notable challenges with the ReNu Phase III trial results, delays in LCD coverage submission, a slight decrease in gross profit margin, and a significant decrease in cash position.Company Guidance
Exceeded Revenue Guidance
Sales results exceeded the high end of the guidance range outlined in the second quarter call, driven primarily by better-than-expected growth in sales of Advanced Wound Care products, which increased 31% year-over-year, and Surgical & Sports Medicine products, which increased 25% year-over-year.
Record Revenue Performance
Net product revenue for the third quarter was $150.5 million, up 31% year-over-year and up 49% sequentially.
Positive Adjusted EBITDA
Adjusted EBITDA for the third quarter was $30.1 million compared to adjusted EBITDA of $13.4 million last year.
CMS Policy Favorable for Future Growth
CMS finalized skin substitute classifications based on FDA regulatory status and a per square centimeter payment methodology, which is expected to expand access for PMA products.
ORGO Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
ORGO Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 06, 2025 | $3.89 | $5.63 | +44.73% |
Aug 07, 2025 | $4.52 | $4.56 | +0.88% |
May 08, 2025 | $5.34 | $3.06 | -42.70% |
Feb 27, 2025 | $3.07 | $6.21 | +102.28% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Organogenesis Holdings (ORGO) report earnings?
Organogenesis Holdings (ORGO) is schdueled to report earning on Feb 26, 2026, After Close (Confirmed).
What is Organogenesis Holdings (ORGO) earnings time?
Organogenesis Holdings (ORGO) earnings time is at Feb 26, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ORGO EPS forecast?
ORGO EPS forecast for the fiscal quarter 2025 (Q4) is 0.22.